South Okanagan cannabis production site sold for $20 million

The 114-acre property sold for $7 million just last year

Western Investor
June 17, 2019

production plant
Rendering for the planned 759,000-square-foot production plant. | Sunniva Inc.
An incomplete cannabis production plant in Okanagan Falls has changed hands for $20 million. 
Sunniva Inc. is selling the 114-acre property to CannaPharmaRx, Inc. Sunniva will receive a net closing profit of $15.5 million upon closing, expected to occur around July 5, 2019. 
The company claims to have sold to property to focus on its production facilities stateside.  
"Sunniva is focused on the advancement of our California assets and expanding our sales and distribution infrastructure in the state to support our continued growth in this rapidly evolving market,” said Dr. Anthony Holler, CEO of Sunniva Inc. “The disposition of the Okanagan Falls property is part of this strategy as we are directing our efforts and capital resources towards the completion of the Cathedral City facility and the ongoing development of our cannabis brands in California."
The site has plans for a 759,000-sqaure-foot greenhouse. Sunniva purchased the site last May for $7 million. 
 The sale provides the Calgary-based investment firm CannaPharmaRx with the opportunity to gain a stronger foothold in the cannabis production industry in Canada. 
The acquisition and development of the Okanagan Falls property, combined with our Hanover, Ontario property and ownership interest in GN Ventures Ltd., sets the stage for the next step in CannaPharmaRx's growth strategy to become a significant player in the Canadian cannabis industry while continuing to strive to maximize shareholder value," said Dominic Colvin, CEO of CannaPharmaRx. 

Tanya is Western Investor's web content and social media coordinator. She first joined the Western Investor team as a editorial assistant in 2016, after a summer spent freelancing at Glacier Media papers The Burnaby Now and New West Record. She is a graduate of Langara College's journalism program.
Copyright © Western Investor

Email to a Friend

Most Popular
Get the Newsletter